Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Molecular Diagnosis of Hemophilia B Leyden in Japanese Brothers Reveals Spontaneous Amelioration in Early Childhood with c. -35 G>A Onecut Binding Site Mutation

Akihiro Tamura, MD, Daiichiro Hasegawa, MD PhD, Sayaka Nakamura, MD, Takahiro Fujiwara, MD, Teppei Tahara, MD, Nobuyuki Yamamoto, MD PhD, Atsuro Saito, MD, Aiko Kozaki, MD, Kenji Kishimoto, MD, Toshiaki Ishida, MD PhD, Keiko Shinozawa, PhD, Kagehiro Amano, MD PhD, Katsuyuki Fukutake, MD PhD, Yoshiyuki Kosaka, MD, PhD

Blood (2017) 130 (Supplement 1): 3680.

https://doi.org/10.1182/blood.V130.Suppl_1.3680.3680

Published: 2017

Journal Articles

The Genetic Analysis of Hemophilia a: The Application of Next-Generation Sequencing in the Analysis of Causative Variants Deep inside the Intron of the F8 Gene

Hiroshi Inaba, PhD, Keiko Shinozawa, PhD, Kagehiro Amano, MD PhD, Katsuyuki Fukutake, MD PhD

Blood (2016) 128 (22): 1393.

https://doi.org/10.1182/blood.V128.22.1393.1393

Published: 2016

Journal Articles

Safety and Efficacy of Recombinant Factor XIII (FXIII) in Patients with Congenital FXIII A-Subunit Deficiency, Results from the Mentor™2 Trial

Manuel Carcao, Carmen Altisent, PhD, Giancarlo Castaman, Katsuyuki Fukutake, MD PhD, Aida Inbal, MD, Bryce A. Kerlin, Craig M. Kessler, MD, Riitta Lassila, MD PhD, Johannes Oldenburg, Prof, Anders Rosholm, May-Lill Garly, MD PhD, Diane J. Nugent, MD

Blood (2016) 128 (22): 2573.

https://doi.org/10.1182/blood.V128.22.2573.2573

Published: 2016

Journal Articles

New Data on the Safety and Efficacy of Recombinant FXIII in Patients with Congenital FXIII A-Subunit Deficiency

Katsuyuki Fukutake, MD PhD, Manual Carcao, MD, Aida Inbal, MD, Bryce A. Kerlin, MD, Johannes Oldenburg, MD PhD, Anders Rosholm, MSc, PhD, May-Lill Garly, MD PhD, Diane J. Nugent, MD

Blood (2014) 124 (21): 1520.

https://doi.org/10.1182/blood.V124.21.1520.1520

Published: 2014

Journal Articles

Safety and Prophylactic Efficacy Profiles of ACE910, a Humanized Bispecific Antibody Mimicking the FVIII Cofactor Function, in Japanese Hemophilia A Patients Both without and with FVIII Inhibitors: First-in-Patient Phase 1 Study

Midori Shima, MD PhD, Hideji Hanabusa, MD, Masashi Taki, MDPhD, Tadashi Matsushita, MD PhD, Tetsuji Sato, MD, Katsuyuki Fukutake, MD PhD, Naoki Fukazawa, Shingo Maisawa, Koichiro Yoneyama, Keiji Nogami, MD PhD

Blood (2014) 124 (21): 691.

https://doi.org/10.1182/blood.V124.21.691.691

Published: 2014

Journal Articles

Evaluation of the Safety, Efficacy of Recombinant Factor IX (nonacog alfa) in Japanese Patients with Hemophilia B- Interim Result of Post Marketing Surveillance Study -

Takashi Suzuki, MD, PhD, Katsuyuki Fukutake, MD, PhD, Kagehiro Amano, MD, PhD, Hideji Hanabusa, MD, Masashi Taki, MD, PhD, Tadashi Matsushita, MD, PhD, Midori Shima, MD, PhD, Michio Sakai, MD, PhD, Masahiro Iizuka, Yoshiyuki Shibasaki

Blood (2012) 120 (21): 3378.

https://doi.org/10.1182/blood.V120.21.3378.3378

Published: 2012

Journal Articles

Mechanism of the Potent Activated Protein C Resistance of Novel Factor V Mutation with W1920R (FV Nara) Relative to R506Q (FV Leiden)

Kenichi Ogiwara, MD, PhD, Keiko Shinozawa, PhD, Keiji Nogami, MD, PhD, Tomoko Matsumoto, Katsumi Nishiya, MD, PhD, Nobuyuki Tsujii, MD, Koji Yada, MD, Katsuyuki Fukutake, MD, PhD, Midori Shima, MD, PhD

Blood (2011) 118 (21): 537.

https://doi.org/10.1182/blood.V118.21.537.537

Published: 2011

Journal Articles

The Etiology of Hemophilia Hiding Deep Inside the F8 Intronic Sequence

Hiroshi Inaba, PhD, Keiko Shinozawa, PhD, Takeshi Hagiwara, MD, PhD, Kagehiro Amano, MD, PhD, Katsuyuki Fukutake, MD, PhD

Blood (2011) 118 (21): 1223.

https://doi.org/10.1182/blood.V118.21.1223.1223

Published: 2011

Journal Articles

Severe Factor V Deficiency Caused by a Novel Compound Heterozygous Mutation: Factor V G1617V and 1-Bp Insertion

Keiko Shinozawa, PhD, Yuri Okimoto, MD, PhD, Kagehiro Amano, MD, PhD, Harumi Kakuda, MD, PhD, Takeshi Hagiwara, MD, PhD, Takashi Suzuki, MD, PhD, Hiroshi Inaba, PhD, Katsuyuki Fukutake, MD, PhD

Blood (2011) 118 (21): 2268.

https://doi.org/10.1182/blood.V118.21.2268.2268

Published: 2011

Journal Articles

Identification and Characterization of L1-Mediated Large Tandem Duplication, Spanning Exon 4 to 10 of the F13A1 , In a Patient with Congenital Factor XIII Deficiency.

Hiroshi Inaba, PhD, Keiko Shinozawa, PhD, Kagehiro Amano, MD, PhD, Katsuyuki Fukutake, MD, PhD

Blood (2010) 116 (21): 3659.

https://doi.org/10.1182/blood.V116.21.3659.3659

Published: 2010

Journal Articles

The Severity of Bleeding Tendency in 5 Patients with Factor V Deficiency Due to Distinct Kinds of Factor V Mutations.

Keiko Shinozawa, PhD, Kagehiro Amano, MD, PhD, Takashi Suzuki, MD, PhD, Hiroshi Inaba, PhD, Katsuyuki Fukutake, MD, PhD

Blood (2007) 110 (11): 1764.

https://doi.org/10.1182/blood.V110.11.1764.1764

Published: 2007

NARROW

Molecular Diagnosis of Hemophilia B Leyden in Japanese Brothers Reveals Spontaneous Amelioration in Early Childhood with c. -35 G>A Onecut Binding Site Mutation

The Genetic Analysis of Hemophilia a: The Application of Next-Generation Sequencing in the Analysis of Causative Variants Deep inside the Intron of the F8 Gene

Safety and Efficacy of Recombinant Factor XIII (FXIII) in Patients with Congenital FXIII A-Subunit Deficiency, Results from the Mentor™2 Trial

New Data on the Safety and Efficacy of Recombinant FXIII in Patients with Congenital FXIII A-Subunit Deficiency

Safety and Prophylactic Efficacy Profiles of ACE910, a Humanized Bispecific Antibody Mimicking the FVIII Cofactor Function, in Japanese Hemophilia A Patients Both without and with FVIII Inhibitors: First-in-Patient Phase 1 Study

Evaluation of the Safety, Efficacy of Recombinant Factor IX (nonacog alfa) in Japanese Patients with Hemophilia B- Interim Result of Post Marketing Surveillance Study -

Mechanism of the Potent Activated Protein C Resistance of Novel Factor V Mutation with W1920R (FV Nara) Relative to R506Q (FV Leiden)

The Etiology of Hemophilia Hiding Deep Inside the F8 Intronic Sequence

Severe Factor V Deficiency Caused by a Novel Compound Heterozygous Mutation: Factor V G1617V and 1-Bp Insertion

Identification and Characterization of L1-Mediated Large Tandem Duplication, Spanning Exon 4 to 10 of the F13A1 , In a Patient with Congenital Factor XIII Deficiency.

The Severity of Bleeding Tendency in 5 Patients with Factor V Deficiency Due to Distinct Kinds of Factor V Mutations.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only